1. Extracellular Vesicle Application as a Novel Therapeutic Strategy for Ischemic Stroke
- Author
-
Xingping Quan, Yan Han, Yiyang Li, Ying Zheng, Yonghua Zhao, Bowen Liu, and Ying Chen
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Neurology ,business.industry ,General Neuroscience ,medicine.medical_treatment ,Therapeutic effect ,Extracellular vesicle ,Thrombolysis ,Bioinformatics ,Extracellular vesicles ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Ischemic stroke ,medicine ,Neurology (clinical) ,Progenitor cell ,Cardiology and Cardiovascular Medicine ,business ,030217 neurology & neurosurgery ,Therapeutic strategy - Abstract
Ischemic stroke (IS) accounts for most of the cases of stroke onset, and due to short therapeutic time window for thrombolysis and numerous limited treatment measures and contraindications, lots of patients cannot receive satisfying therapeutic effects resulting in high disability and mortality worldly. In recent years, extracellular vesicles (EVs), as nanosized membrane-structured vesicles secreted from almost all cells, especially from stem/progenitor cells, have been reported to exert significant beneficial effects on IS from multiple approaches and notably ameliorate neurological outcome. Moreover, based on nano-size and lipid bilayer structure, EVs can easily penetrate the blood-brain barrier and migrate into the brain. In this review, we mainly systematically summarize the therapeutic effects of EVs on IS and explore their potential applications. Simultaneously, we also discuss administration routines, dosages, experimental observation time, and some key issues of EV application during IS treatment. It contributes to a comprehensive understanding of the progress of EV treatment for IS and providing confident evidence for further EV clinical application widely.
- Published
- 2021